Platinum-Resistant Disease
specificA finding indicating that a cancer is resistant to platinum therapy. For non-gynecologic cancers, the terms "platinum-resistant" and "platinum-refractory" are used interchangeably. For gynecologic cancers, it refers to cancer progression between one and six months of completing the last platinum therapy.
Top Centers for Platinum-Resistant Disease
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →